Allianz Asset Management
BSX icon

Allianz Asset Management’s Boston Scientific BSX Stock Holding History

Allianz Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65M Buy
58,200
+7,800
+15% +$624K ﹤0.01% 1312
2025
Q4 		$4.81M Buy
50,400
+29,100
+137% +$2.85M ﹤0.01% 1156
2025
Q3 		$2.08M Sell
21,300
-36,300
-63% -$3.76M ﹤0.01% 1481
2025
Q2 		$6.19M Buy
57,600
+9,300
+19% +$941K 0.01% 1005
2025
Q1 		$4.87M Buy
48,300
+19,400
+67% +$1.95M 0.01% 1121
2024
Q4 		$2.58M Buy
28,900
+6,300
+28% +$555K ﹤0.01% 1324
2024
Q3 		$1.89M Buy
22,600
+9,600
+74% +$757K ﹤0.01% 1430
2024
Q2 		$1M Sell
13,000
-14,200
-52% -$1.04M ﹤0.01% 1589
2024
Q1 		$1.86M Sell
27,200
-13,600
-33% -$874K ﹤0.01% 1203
2023
Q4 		$2.36M Sell
40,800
-50,200
-55% -$2.68M ﹤0.01% 1260
2023
Q3 		$4.8M Buy
91,000
+24,100
+36% +$1.26M 0.01% 1007
2023
Q2 		$3.62M Buy
66,900
+48,600
+266% +$2.54M 0.01% 997
2023
Q1 		$916K Buy
18,300
+6,700
+58% +$316K ﹤0.01% 1715
2022
Q4 		$537K Buy
11,600
+10,100
+673% +$437K ﹤0.01% 1709
2022
Q3 		$58K Sell
1,500
-6,200
-81% -$249K ﹤0.01% 1725
2022
Q2 		$287K Sell
7,700
-21,900
-74% -$891K ﹤0.01% 2021
2022
Q1 		$1.31M Buy
29,600
+13,600
+85% +$589K ﹤0.01% 1742
2021
Q4 		$680K Sell
16,000
-23,500
-59% -$988K ﹤0.01% 2080
2021
Q3 		$1.71M Buy
39,500
+29,800
+307% +$1.32M ﹤0.01% 1709
2021
Q2 		$415K Buy
+9,700
New +$408K ﹤0.01% 2131
2020
Q3 		– Sell
-64,600
Closed -$2.27M – 1926
2020
Q2 		$2.27M Buy
64,600
+18,200
+39% +$655K ﹤0.01% 1551
2020
Q1 		$1.51M Sell
46,400
-42,700
-48% -$1.67M ﹤0.01% 1626
2019
Q4 		$4.03M Sell
89,100
-3,500
-4% -$146K ﹤0.01% 1578
2019
Q3 		$3.77M Buy
92,600
+12,600
+16% +$534K ﹤0.01% 1579
2019
Q2 		$3.44M Buy
80,000
+50,000
+167% +$1.92M ﹤0.01% 1674
2019
Q1 		$1.15M Buy
30,000
+13,900
+86% +$531K ﹤0.01% 2042
2018
Q4 		$569K Sell
16,100
-2,900
-15% -$105K ﹤0.01% 2230
2018
Q3 		$732K Sell
19,000
-3,500
-16% -$122K ﹤0.01% 2310
2018
Q2 		$736K Buy
22,500
+8,600
+62% +$259K ﹤0.01% 2311
2018
Q1 		$380K Sell
13,900
-176,200
-93% -$4.79M ﹤0.01% 2443
2017
Q4 		$4.71M Buy
190,100
+8,000
+4% +$221K ﹤0.01% 1652
2017
Q3 		$5.31M Buy
182,100
+21,100
+13% +$583K ﹤0.01% 1591
2017
Q2 		$4.46M Buy
161,000
+65,200
+68% +$1.73M ﹤0.01% 1641
2017
Q1 		$2.38M Sell
95,800
-87,500
-48% -$2.13M ﹤0.01% 1933
2016
Q4 		$3.96M Buy
183,300
+58,300
+47% +$1.27M ﹤0.01% 1728
2016
Q3 		$2.98M Buy
125,000
+51,900
+71% +$1.24M ﹤0.01% 1832
2016
Q2 		$1.71M Buy
73,100
+54,000
+283% +$1.17M ﹤0.01% 1998
2016
Q1 		$359K Buy
+19,100
New +$336K ﹤0.01% 2316
2015
Q3 		– Sell
-23,000
Closed -$407K – 2327
2015
Q2 		$407K Buy
+23,000
New +$411K ﹤0.01% 2184

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Allianz Asset Management's BSX Position: Q1 2026 in Review

Allianz Asset Management increased its Boston Scientific (BSX) stake by 20% in Q1 2026, buying an estimated $31.5M and bringing the position to 2,393,824 shares worth $150M. The position accounts for 0.16% of the portfolio, ranked #126.

Allianz Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $363M in Q2 2019. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Allianz Asset Management held 2,393,824 shares of Boston Scientific worth $150M as of Q1 2026.
  • Allianz Asset Management bought 394,232 Boston Scientific shares in Q1 2026, an estimated $31.5M.
  • Boston Scientific made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #126 holding.
  • Allianz Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Boston Scientific position peaked at $363M in Q2 2019.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.